Anna Cattau, NP
Family · Lenexa, KSNPI 1932532629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 410 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,665 and has fallen 95.3% since, to $126 in 2024. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $17.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$958
- Lilly USA, LLC$826
- GSK$419
- Johnson & Johnson$405
- Pfizer$348
- plus $3K from 33 others
What the payments were for
- Food & beverage$7,240100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 74 | $1,445 |
| Novo Nordisk | 52 | $958 |
| Lilly USA, LLC | 49 | $826 |
| GSK | 29 | $419 |
| Johnson & Johnson | 26 | $405 |
| Pfizer | 31 | $348 |
| AstraZeneca | 16 | $310 |
| Radius Health, Inc. | 10 | $244 |
| Abbott | 13 | $233 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $221 |
| Amgen | 11 | $220 |
| Eisai Inc. | 5 | $195 |
| Boehringer Ingelheim | 10 | $178 |
| Amarin Pharma, Inc. | 10 | $151 |
| Nevro Corp. | 6 | $127 |
| Merck | 8 | $126 |
| Boston Scientific | 4 | $80 |
| Novartis | 5 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $68 |
| Neurocrine Biosciences, Inc. | 3 | $62 |
| Currax Pharmaceuticals LLC | 4 | $52 |
| Biogen | 2 | $48 |
| Idorsia Pharmaceuticals US Inc | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $45 |
| IBSA Pharma Inc. | 2 | $42 |
| Jazz Pharmaceuticals Inc. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Bayer | 2 | $29 |
| Sanofi Pasteur Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 2 | $26 |
| Irhythm Technologies, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Endogastric Solutions, Inc | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,251 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 46 | $289 |
| Alendronate Sodium | 33 | $179 |
| Rosuvastatin Calcium | 16 | $165 |
| Metoprolol Succinate | 13 | $106 |
| Levothyroxine Sodium | 21 | $86 |
| Lisinopril | 22 | $57 |
| Metformin Hcl | 11 | $54 |
| Meloxicam | 14 | $36 |
| Simvastatin | 20 | $30 |
| Allopurinol | 12 | $24 |
| Amlodipine Besylate | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other family in Lenexa
- Jennifer AndersonLenexa$9K
- Zohra HussainiKansas City$329K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
- Kayla del RioWichita$147K
- Kelli RiceWichita$114K
- Tatum TolandTopeka$108K
- Mary GonzalesWichita$87K
- Erin FeitzOverland Park$36K
- Adam CaseKansas City$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.